analyst
NYSE · RMD
ResMed Inc.
Healthcare · Medical - Instruments & Supplies
$224.99
Down-$3.43 (-1.50%)
Updated Sep 20, 2026, 12:31 PM
SID Score
6.0/10
Composite research score
Smart Money
62/100
Neutral
- Market cap
- 36.98B
- P/E ratio
- 25.71
- Dividend yield
- 1.00%
- 52-week range
- $180.27 – $277.67
- Volume
- 3.86M
- Avg. volume
- 1.04M
Price performance
RMD price history
1M range · 19 trading sessions · Daily adjusted prices
RMD closed at $224.99 after 19 trading sessions, down 3.21% for the selected period.
- Last close
- $224.99
- Period change
- -3.21%
- Period low
- $218.27
- Period high
- $240.33
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $228.21 | $228.385 | $224.56 | $224.99 | 3.86M |
| Sep 17, 2026 | $228.25 | $229.57 | $225.08 | $228.42 | 1.09M |
| Sep 16, 2026 | $228.19 | $229.325 | $224.26 | $228.25 | 1.07M |
| Sep 15, 2026 | $226.36 | $234.33 | $225.115 | $229.44 | 1.64M |
| Sep 14, 2026 | $221.04 | $225.82 | $220.94 | $222.99 | 989.01K |
| Sep 11, 2026 | $220.44 | $221.29 | $215.97 | $218.27 | 912.33K |
| Sep 10, 2026 | $217.93 | $221.253 | $215.80 | $219.58 | 923.14K |
| Sep 9, 2026 | $220.845 | $220.845 | $217.00 | $219.95 | 1.2M |
| Sep 8, 2026 | $226.22 | $226.665 | $220.445 | $221.05 | 1.96M |
| Sep 4, 2026 | $225.91 | $228.49 | $225.12 | $228.35 | 843.84K |
| Sep 3, 2026 | $231.20 | $233.045 | $227.265 | $229.19 | 1.48M |
| Sep 2, 2026 | $234.73 | $237.21 | $230.78 | $230.87 | 1.16M |
| Sep 1, 2026 | $239.90 | $242.40 | $230.175 | $231.36 | 987.08K |
| Aug 31, 2026 | $237.97 | $241.71 | $236.16 | $240.10 | 1.72M |
| Aug 28, 2026 | $236.64 | $241.06 | $235.01 | $240.33 | 1.39M |
| Aug 27, 2026 | $233.06 | $237.94 | $232.29 | $235.76 | 1.59M |
| Aug 26, 2026 | $233.66 | $237.76 | $232.10 | $235.69 | 1.54M |
| Aug 25, 2026 | $232.22 | $238.37 | $231.885 | $236.59 | 1.76M |
| Aug 24, 2026 | $231.00 | $233.23 | $228.87 | $232.45 | 1.11M |
Latest RMD news
The latest Smart Investors Daily articles mentioning RMD.
Stock researchResearch & News · Analysis
Loading stock research…